Trump: Generic drugs to be subject to tariffs in 2028
AI Briefing
- * President Trump plans to impose tariffs on generic drugs in 2028.
- * This move has left generic drug companies uncertain about future costs.
- * Trump's tariff plan aims to level playing field with pharmaceutical companies.
Context
President Donald Trump has been considering tariffs on the U.S. biopharma sector. Generic drug companies have been waiting to see if they would be subject to these tariffs.
Generic drug companies will be subject to tariffs in 2028, according to Trump. The tariffs will impact the companies that have had a tariff-free status until now.
Advertisement